ACE and heart valve disorder: BMI; history of stroke; initial mean BP; initial RR; NYHA class IV; concomitant AF; ACS; valvular heart disease (VHD); prescribed angiotensin-converting enzymes inhibitors; and baseline NLR, MPV, MPVLR, and PLR were statistically significant covariates of CVE outcomes.